CG FV (Femara 2.5 mg)
Generic Name: letrozole
Pill imprint CG FV has been identified as Femara 2.5 mg.
Femara is used in the treatment of female infertility; breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Femara 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- letrozole
- Imprint:
- CG FV
- Strength:
- 2.5 mg
- Color:
- Yellow
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Aromatase inhibitors
Hormones/antineoplastics - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0249
- Inactive Ingredients:
- silicon dioxide
ferric oxide red
hypromelloses
lactose monohydrate
magnesium stearate
corn starch
microcrystalline cellulose
polyethylene glycol
sodium starch glycolate type A potato
magnesium silicate
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4151 | Physicians Total Care Inc (repackager) |
| 54569-5714 | A-S Medication Solutions, LLC (repackager) |
| 35356-0409 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
More about Femara (letrozole)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
